Teladoc Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Teladoc Health Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TDOC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001477449
Board of directors
-
Catherine Jacobson · DirectorSince 2023
-
Charles Divita III · Director · CHIEF EXECUTIVE OFFICERSince 2024
-
David B. Snow Jr. · DirectorSince 2023
-
David L. Shedlarz · DirectorSince 2023
-
Jason Eric Evans · DirectorSince 2023
-
Jason N. Gorevic · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Karen L. Daniel · DirectorSince 2023
-
Kenneth H. Paulus · DirectorSince 2023
-
Mark Douglas Smith · DirectorSince 2023
-
Sandra L. Fenwick · DirectorSince 2023
-
Thomas Mckinley · DirectorSince 2023
Chief executives
Charles Divita III
· CHIEF EXECUTIVE OFFICER
Since June 2024
Jason N. Gorevic
· CHIEF EXECUTIVE OFFICER
Until June 2024
· Former
Board connections
4 of this board's directors also sit on 6 other boards.
- via Karen L. Daniel
- via Mark Douglas Smith
- via Jason N. Gorevic
- via Mark Douglas Smith
- via David L. Shedlarz
- via Karen L. Daniel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2024 | Raman-Tangella Vidya Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −468 | $11.04 | $5,167 |
| Jun 3, 2024 | Waters Michael Willem Officer (CHIEF OPERATING OFFICER) | Open-market sale | −4,246 | $11.16 | $47,385 |
| Jun 3, 2024 | Kornwasser Laizer Officer (PRESIDENT, ENTERPRISE GROWTH) | Open-market sale | −4,812 | $11.16 | $53,702 |
| Jun 3, 2024 | Geshuri Arnnon Officer (CHIEF PEOPLE OFFICER) | Open-market sale | −1,807 | $11.16 | $20,166 |
| Jun 3, 2024 | Turitz Andrew Officer (EVP, CORPORATE DEVELOPMENT) | Open-market sale | −1,627 | $11.16 | $18,157 |
| Jun 3, 2024 | Raman-Tangella Vidya Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −1,122 | $11.16 | $12,522 |
| Jun 3, 2024 | Trencher Daniel Officer (CHIEF STRATEGY OFFICER) | Open-market sale | −1,790 | $11.16 | $19,976 |
| Jun 3, 2024 | Verstraete Stephany Officer (CHIEF MARKETING OFFICER) | Open-market sale | −2,096 | $11.16 | $23,391 |
| Jun 3, 2024 | Vandervoort Adam C Officer (CHIEF LEGAL OFFICER, SECRETARY) | Open-market sale | −4,015 | $11.16 | $44,807 |
| Jun 3, 2024 | Mala Murthy Officer (ACTING CEO, CFO) | Open-market sale | −8,807 | $11.16 | $98,286 |
| Jun 3, 2024 | Cave James L. Officer (INTERIM CAO) | Open-market sale | −854 | $11.16 | $9,531 |
| Jun 3, 2024 | Nanis Nikolaos P. Officer (Chief Technology Officer) | Open-market sale | −1,040 | $11.16 | $11,606 |
| May 31, 2024 | Mala Murthy Officer (ACTING CEO, CFO) | Option exercise | +2,641 | — | — |
| May 31, 2024 | Geshuri Arnnon Officer (CHIEF PEOPLE OFFICER) | Option exercise | +977 | — | — |
| May 31, 2024 | Turitz Andrew Officer (EVP, CORPORATE DEVELOPMENT) | Option exercise | +1,056 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.